NeoGenomics Laboratories

About NeoGenomics Laboratories

NeoGenomics Laboratories is a leading provider of cancer-focused genetic testing services, dedicated to advancing the field of oncology through innovative diagnostic solutions. Established with the vision of improving patient outcomes, the company offers a comprehensive range of tests that assist healthcare professionals in making informed treatment decisions.

With a commitment to quality and accuracy, NeoGenomics employs state-of-the-art technology and a team of expert pathologists and geneticists. Their extensive test menu includes molecular profiling, cytogenetics, and next-generation sequencing, catering to various cancer types.

NeoGenomics Laboratories also prioritises research and development, continuously striving to enhance their testing capabilities and expand their offerings. The company collaborates with leading academic institutions and pharmaceutical companies to contribute to groundbreaking studies and clinical trials.

In addition to their testing services, NeoGenomics provides educational resources and support for healthcare providers, ensuring they are well-equipped to interpret results and implement personalised treatment plans.

As a trusted partner in cancer care, NeoGenomics Laboratories is committed to delivering timely and reliable results, empowering clinicians and patients alike in the fight against cancer.

• Core Activities: Cancer genetic testing, molecular profiling, cytogenetics, next-generation sequencing.
• Vision: To improve patient outcomes through innovative diagnostic solutions.
• Commitment: Quality, accuracy, and continuous research and development.